Skip to main content
. 2005 Oct;167(4):1051–1059. doi: 10.1016/s0002-9440(10)61194-7

Figure 5.

Figure 5

Significant proliferative responses of PBMCs were seen with AFN peptide in the patients with primary SS. Nine of eighteen SS patients examined reacted significantly with single AFN peptide, but not in SLE (n = 6), RA (n = 5), and age-matched healthy controls (n = 6). Representative profiles in three different patients with SS (SS 1, SS 2, SS 3) indicate significant proliferative responses with peptide mixture and individual peptide of p22, p26, p28, and p39 (*P < 0.05, **P < 0.01; Student’s t-test), but not with laminin fragment peptide 929-933 as control antigen. The results are expressed as stimulation indices ± SEM.